Bliss GVS Pharma posts Q3 FY23 consolidated PAT at Rs. 27.94 Cr
News

Bliss GVS Pharma posts Q3 FY23 consolidated PAT at Rs. 27.94 Cr

The company has reported total income of Rs. 211.36 crores during the period ended December 31, 2022

  • By IPP Bureau | January 28, 2023

Bliss GVS Pharma Limited has posted net profit of Rs. 27.94 crores for the period ended December 31, 2022 as against net profit of Rs. 13.85 crores for the period ended September 30, 2022. The company posted net loss of Rs.50.11 crores for the period ended December 31, 2021.

The company has reported total income of Rs. 211.36 crores during the period ended December 31, 2022 as compared to Rs. 174.58 crores during the period ended September 30, 2022. Bliss GVS Pharma reported total income Rs.222.29 crores during the period ended December 31, 2021. 

The company has reported total income of Rs.581.61 crores during the 9-month period ended December 31, 2022 as compared to Rs.599.69 crores during the 9-month period ended December 31, 2021.

The company has posted net profit of Rs.67.51 crores for the 9-month period ended December 31, 2022 as against net loss of Rs. 4.59 crores for the 9-month period ended December 31, 2021.

Upcoming E-conference

Other Related stories

Startup

Digitization